TALVEY (talquetamab) Patient Assistance Program
A myeloma diagnosis is heavy enough without a five-figure monthly drug bill. The Johnson & Johnson Patient Assistance Program provides Talvey free of charge to eligible patients — and we manage the entire enrollment, for the patient or the family member coordinating care, for a flat $69.95 per month.
- Clear & Transparent Pricing — Applying To J&J Directly Is Always Free
- Paperwork, Documentation & Treatment-Center Coordination Handled For You
- Comprehensive Support: From Application to Entire Journey.
- Annual Re-certification And Refills Management
- We Untangle The Two Bills: The Drug Itself And The Hospital/Clinic Administration
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Talvey (Talquetamab) Is A First-In-Class Bispecific Antibody For Heavily Pretreated Relapsed/Refractory Multiple Myeloma — A Weekly Or Biweekly Injection Given By Healthcare Providers Under A REMS Safety Program, With Hospitalization Recommended For 48 Hours After Each Step-Up Dose.
- Talvey Launched At Roughly $45,000 Per Month — A 6–8 Month Course Can Run $270,000–$360,000 In Drug Cost Alone, Before Administration And Hospitalization Charges. No Biosimilar Exists Or Is Coming Soon.
- The Johnson & Johnson Patient Assistance Program Provides Talvey Free To Patients With Household Income At Or Below 300% Of The Federal Poverty Level ($46,950 Single / $96,450 Family Of Four) — Uninsured Or Inadequately Insured, Including Medicare.
- Commercially Insured Patients Pay $5 Per Dose Through Talvey withMe — Up To $26,000 Per Calendar Year, One Of The Largest Copay Benefits In Oncology. Note What It Doesn’t Cover: Administration And Hospitalization Fees Bill Separately.
What Is Talvey Prescription Assistance Program?
The Talvey Patient Assistance Program is run by the Johnson & Johnson Patient Assistance Program and provides Talvey free of charge to qualifying patients: household income at or below 300% of the Federal Poverty Level, uninsured or inadequately covered — including Medicare patients (those at or below 150% FPL must first show ineligibility for the Extra Help subsidy). Approvals cover up to a year, re-enrolled each calendar year. Applying directly (833-742-0791, Mon–Fri 8 AM–8 PM ET) is always free. Talvey’s real financial complexity is structural: as a provider-administered drug it bills through the medical benefit (Medicare Part B, not Part D — so the $2,100 pharmacy cap never applies), every step-up dose comes with a recommended 48-hour hospitalization that generates its own facility bill, and the REMS program adds certified-site requirements. Assistance for the drug, the administration, and the hospital stay run on three separate tracks. For a flat $69.95 per month, our Patient Advocates coordinate all three with your cancer center’s financial team — so the family can focus on treatment, not invoices.
Pharmacy Price Comparison
- Without assistance, Talvey costs roughly $30,000–$45,000 per month. A Patient Assistance Program is the meaningful path forward — if you qualify:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Step-up dose 1 (Day 1) | ~$3,000.00 | Save thousand |
| Full weekly dose | ~$10,000.00 | Save ~$9,930/dose |
| Weekly dosing (monthly total) | ~$40,000+ | Save ~$39,930/mo |
| Every-2-week dosing | ~$20,000+/mo | Save ~$19,930/mo |
| Annual cost (typical) | ~$400,000+ | Save ~$399,000+/yr |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Talvey Prescription Program?
The J&J Patient Assistance Program is free to apply for and provides Talvey at no drug cost if approved. Our $69.95/month service covers full advocacy — coordinating the drug, administration, and facility tracks with your cancer center, for however long treatment runs.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Talvey:
Limitations of Coupons
- Prices fluctuate — savings aren’t guaranteed month-to-month
- Copay accumulators may prevent savings from counting toward deductible
- Coupon cards expire and require constant renewal
Still $30,000–$45,000 per month even with the best discount
- Can’t be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
- Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
- Medication supplied directly through the assistance program
- We manage all paperwork, refills, and annual renewals
- If denied, we explore alternative savings on your behalf
DO YOU QUALIFY?
The Johnson & Johnson Patient Assistance Program publishes clear eligibility rules for free Talvey. You will generally qualify if all of the following are true — and if your situation doesn’t fit neatly, contact AffordMyPrescriptions so we can review your case and determine if you qualify for Talvey assistance:
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid Talvey Prescription And Are Being Treated At A REMS-Enrolled Center
- You Are Uninsured Or Inadequately Insured — Including Medicare (At Or Below 150% FPL Requires Extra Help Ineligibility First)
- Your Household Income Is At Or Below 300% Of The Federal Poverty Level — $46,950 (Single) Up To $96,450 (Family Of Four)
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Understanding Talvey:
Talvey (talquetamab) is a first-in-class bispecific antibody for relapsed/refractory multiple myeloma — one arm grabs GPRC5D on myeloma cells, the other grabs CD3 on the patient’s own T-cells, physically pulling immune killers onto the cancer.
How Talvey Works:
Multiple myeloma cells express GPRC5D on their surface far more than healthy cells do. Talquetamab bridges those cells directly to T-cells, forcing an immune attack that doesn’t depend on the exhausted, heavily pretreated immune system finding the cancer on its own. It’s approved for patients who’ve been through at least four prior lines of therapy — the population with the fewest options — and targets a different antigen than BCMA-directed therapies, so it can work after they fail.
Form and Use:
Given as a subcutaneous injection by healthcare providers — never self-administered — starting with step-up doses that acclimate the immune system, each followed by a recommended 48-hour hospitalization to monitor for cytokine release syndrome. Maintenance is weekly or every two weeks, at a REMS-certified site. The financial architecture follows the clinical one: drug cost, administration fees, and step-up hospital stays are three different bills with three different assistance answers — which is why the coordination matters as much as any single program.
Biosimilar Availability:
None exists or is on any near-term horizon — talquetamab was approved in 2023 and holds long exclusivity as a first-in-class biologic. The cost levers are the withMe program, the J&J PAP, supplemental Medicare coverage, hospital financial assistance, and myeloma-specific foundations (LLS, HealthWell’s myeloma funds when open) — several of which can stack.
Warnings:
Talvey carries boxed warnings for cytokine release syndrome and neurologic toxicity including ICANS — the reason for step-up hospitalization and REMS monitoring. Its signature side effects are unusual: taste changes (dysgeusia), dry mouth, nail and skin changes — quality-of-life issues worth reporting rather than enduring, since dose adjustments help. Infections and low blood counts are common; report fevers immediately. Patients shouldn’t drive for 48 hours after step-up doses.
FAQ (Frequently Asked Questions)
How Much Does Talvey Cost Without Insurance?
Talvey launched at roughly $45,000 per month — $270,000–$360,000 for a typical 6–8 month course, before administration and hospitalization charges. Patients at or below 300% of the Federal Poverty Level can receive the drug free through the J&J Patient Assistance Program; our $69.95 monthly fee covers coordinating that plus the non-drug bills.
Does Medicare Cover Talvey?
Yes — under Part B as a provider-administered drug (HCPCS J3055), with 20% coinsurance that the $2,100 Part D cap does not touch. A Medigap policy or Medicare Advantage out-of-pocket maximum is what contains the exposure — and income-eligible Medicare patients can route the drug cost through the PAP instead. We map which applies before treatment starts.
What Does The $5 withMe Program Actually Cover?
For commercially insured patients: the drug, at $5 per dose, up to $26,000 per calendar year. Not covered: administration fees, monitoring, or the step-up hospitalizations — those go through your medical benefit and the hospital’s own financial assistance, which we pursue in parallel.
Why Do I Have To Be Hospitalized For Step-Up Doses?
Bispecifics can trigger cytokine release syndrome as the immune system engages — the 48-hour recommended stay after each step-up dose exists so it’s caught and treated immediately. It’s in the current label and REMS. Financially, plan for those stays as part of the treatment cost, not a surprise.
Is There A Cheaper Version Or Biosimilar?
No — first-in-class, approved 2023, long exclusivity ahead. Affordability comes from stacking programs, not substitution.
Can Foundation Grants Help Too?
Often, yes — myeloma-specific funds at organizations like the Leukemia & Lymphoma Society and HealthWell open and close through the year, and they can cover cost-sharing the manufacturer programs can’t. We watch fund openings and file fast; the windows are short.
Take Control of Your Medication Costs
Talvey’s price is measured in car-payments per dose — but between the J&J PAP, a $26,000 copay benefit, Part B supplements, hospital charity care, and foundation funds, patients who get the coordination right routinely pay a tiny fraction of list. That coordination is our job. Check your eligibility today; the pre-qualification review is free, and if we can’t help you, you pay nothing.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.